Hyku Biosciences Names Keith Wilcoxen, PhD, As CSO
19 Mar 2025 //
GLOBENEWSWIRE
Hyku Bioscience Appoints John Gustofson to its Board of Directors
12 Nov 2024 //
GLOBENEWSWIRE
Hyku Biosciences Announces CEO Transition for its Next Phase of Growth
11 Mar 2024 //
GLOBENEWSWIRE
Hyku Launches With $56M to Advance its Covalent Medicines Platform
19 Sep 2023 //
ACCESSWIRE